Mission BioCapital


Mission BioCapital is a venture capital firm dedicated to empowering life science entrepreneurs by providing early-stage capital and a collaborative platform to realize their visions. Founded in 2009, the firm focuses on transformative investments in life sciences, including therapeutics, diagnostics, medical devices, and drug delivery. With a commitment to mentorship, innovation, and support, Mission BioCapital partners with life sciences incubators to offer shared lab spaces and strategic guidance, helping startups progress from idea to exit.

Mission BioCapital

Mission BioCapital


What We Do

The Platinum Program offers up to $500,000 in funding, lab space, drug discovery services, legal and accounting support, and mentorship to early-stage life science companies.

Mission BioCapital provides flexible lab space with top-of-the-line equipment in leading biotech ecosystems, allowing entrepreneurs to focus on their science and streamline infrastructure.


Geographic Focus

Investment Stage


Portfolio

Advancing novel cell therapies for T-cell malignancies.

#Therapeutics

Developing a new approach to treating multiple sclerosis.

#Therapeutics

Developing novel therapeutics by engineering tissue-selective growth factors.

#Therapeutics

Developing small molecule HDAC6 inhibitors for human disease treatment.

#Therapeutics

Discovering therapies targeted to the thymus for immune tolerance.

#Therapeutics

Developing therapeutics for undruggable targets.

#Therapeutics


Key People

Director of Operations, Cambridge

Chief Operations Officer and Chief Compliance Officer

Managing General Partner